Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]

NCT07172165 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT07172165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07172165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]
Lead sponsor
Universidade do Porto
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 15, 2025
Completion date
March 15, 2026
Enrollment
850 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microemboli, stroke, transcranial doppler ultrasound